Innate Pharma
IPHA
#8877
Rank
HK$1.34 B
Marketcap
HK$14.34
Share price
-7.11%
Change (1 day)
-15.23%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Innate Pharma CIK: 0001598599
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Innate Pharma only files 20-F reports

Thumbnail Innate Pharma
 20-F Annual Report

20-F Annual Report 2026-04-01

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report

20-F Annual Report 2025-04-30

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report

20-F Annual Report 2024-04-04

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report

20-F Annual Report 2023-04-06

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report

20-F Annual Report 2022-04-04

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report

20-F Annual Report 2021-04-27

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report

20-F Annual Report 2020-04-24

Language: English

View Annual Report (20-F)